Search
Search Results
##search.searchResults.foundPlural##
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1839PDF: 719HTML: 2110Untitled: 219Untitled: 154Untitled: 173Untitled: 157Untitled: 164Untitled: 180Untitled: 185 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2835PDF: 956HTML: 7338 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1541PDF: 723HTML: 232 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3156PDF: 1832HTML: 3658 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1022PDF: 690Html: 159 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1972PDF: 822HTML: 2201Table 1: 179Table 2: 198Table 3: 192Table 4: 194Table 5: 191Tble 6: 184Cover Letter: 205Greene Tab.7: 194 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3928PDF: 1102HTML: 460 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1323PDF: 1136HTML: 121 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1545PDF: 788HTML: 1485Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 180 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1365PDF: 472HTML: 180 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2850PDF: 851HTML: 6527Untitled: 227Untitled: 189Untitled: 206Untitled: 215 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1549PDF: 883HTML: 982figures: 182table 1: 183table2: 182table3: 184 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13262PDF: 972HTML: 7292 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
963PDF: 462HTML: 119 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2458PDF: 788HTML: 1736 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2704PDF: 1010HTML: 2294 -
How I treat acute and persistent sickle cell pain
1940PDF: 1119HTML: 487 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2940PDF: 982HTML: 2064Cover letter: 179 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3978PDF: 1514HTML: 9190Untitled: 280Untitled: 187Untitled: 170Untitled: 165Untitled: 185Untitled: 340 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2113PDF: 993HTML: 4073Cover Letter: 221Figure 1: 235Figure 2: 231Table 1: 205 -
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1269PDF: 602HTML: 1098 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1187PDF: 839HTML: 3364 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3157PDF: 1140HTML: 1491Untitled: 177Untitled: 169Untitled: 168 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
165PDF: 204Suppl. Files: 33HTML: 21







